Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

A recent study found that relatively healthy obesity may reduce the risk of developing Alzheimer's disease.

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

In Japan, clinical use is climbing faster, with about 4,500 people now on the drug. ARIA rates in Japan are half those in the U.S., which was also the case in the Phase 3 Clarity trial. Meanwhile, use ...

Susan Haake was a gifted pianist and organist. She enjoyed golf, loved to entertain guests, and was always ready to offer a smile, a laugh, and a listening ear. Her joyful spirit and deep compassion ...

ALBANY, N.Y. ( NEWS10) — Free memory screenings are available on Thursday afternoon at Mariott Albany on Wolf Road in honor ...

For these two Iona Prep student-athletes, who just happen to be brothers, making a difference is the name of the game.

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.